High mobility group box 1, ATP, lipid mediators, and tissue factor are elevated in COVID‐19 patients: HMGB1 as a biomarker of worst prognosis

The severe acute respiratory syndrome coronavirus 2, the agent of the ongoing coronavirus disease 2019 (COVID‐19) pandemic, has spread worldwide since it was first identified in November 2019 in Wuhan, China. Since then, progress in pathogenesis linked severity of this systemic disease to the hypera...

Descripción completa

Detalles Bibliográficos
Autores principales: Vicentino, Amanda Roberta Revoredo, Fraga‐Junior, Vanderlei da Silva, Palazzo, Matheus, Tasmo, Natalia Recardo Amorim, Rodrigues, Danielle A. S., Barroso, Shana Priscila Coutinho, Ferreira, Sâmila Natiane, Neves‐Borges, Anna Cristina, Allonso, Diego, Fantappié, Marcelo Rosado, Scharfstein, Julio, Oliveira, Ana Carolina, Vianna‐Jorge, Rosane, Vale, André Macedo, Coutinho‐Silva, Robson, Savio, Luiz Eduardo Baggio, Canetti, Claudio, Benjamim, Claudia Farias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087071/
https://www.ncbi.nlm.nih.gov/pubmed/36631939
http://dx.doi.org/10.1111/cts.13475

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087071/
https://www.ncbi.nlm.nih.gov/pubmed/36631939
http://dx.doi.org/10.1111/cts.13475

Ejemplares similares